Home/Filings/4/0000905148-24-002950
4//SEC Filing

Strobeck Matthew 4

Accession 0000905148-24-002950

CIK 0001439725other

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 3:16 PM ET

Size

12.1 KB

Accession

0000905148-24-002950

Insider Transaction Report

Form 4
Period: 2024-11-05
Transactions
  • Purchase

    Common Stock

    2024-11-05$1.40/sh+4,000$5,59289,673 total(indirect: By Birchview Capital Separately Managed Account)
  • Purchase

    Common Stock

    2024-11-05$1.40/sh+36,000$50,3242,606,879 total(indirect: By LLC)
Holdings
  • Common Stock

    (indirect: By UTMA Account)
    119,003
  • Common Stock

    (indirect: By UTMA Account)
    119,003
  • Common Stock

    (indirect: By LLC)
    40,665
  • Common Stock

    (indirect: By UTMA Account)
    119,003
  • Common Stock

    2,542,928
  • Common Stock

    (indirect: By UTMA Account)
    119,003
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.38 to $1.405, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F3]The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F4]The Reporting Person is an affiliate of Clajer Capital LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Documents

1 file

Issuer

BIODESIX INC

CIK 0001439725

Entity typeother

Related Parties

1
  • filerCIK 0001377832

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 3:16 PM ET
Size
12.1 KB